We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Chunghwa Telecom
CHT
$33.4B
| $386K | ﹤0.01% |
9,483
-2,610
| -22% | -$106K |
|
777
Sea Limited
SE
$64.1B
| $378K | ﹤0.01% |
1,375
+125
| +10% | +$31.7K |
|
778
Zions Bancorporation
ZION
$10B
| $378K | ﹤0.01% |
7,147
-7,895
| -52% | -$442K |
|
|
GAP
779
The Gap Inc
GAP
$7.06B
| $368K | ﹤0.01% |
10,937
-5,664
| -34% | -$187K |
|
|
CIXX
780
DELISTED
CI Financial Corp.
CIXX
| $343K | ﹤0.01% |
18,696
-697,990
| -97% | -$11.9M |
|
781
Amplify Video Game Tech ETF
GAMR
$37.1M
| $318K | ﹤0.01% |
3,335
-320
| -9% | -$31.1K |
|
782
UDR
UDR
$12.8B
| $318K | ﹤0.01% |
6,499
| – | – |
|
|
SJR
783
DELISTED
Shaw Communications Inc.
SJR
| $318K | ﹤0.01% |
+10,956
| New | +$316K |
|
784
Kinross Gold
KGC
$28.4B
| $310K | ﹤0.01% |
48,799
+3,424
| +8% | +$25.4K |
|
785
Petrobras
PBR
$117B
| $308K | ﹤0.01% |
25,150
| – | – |
|
|
EBSB
786
DELISTED
Meridian Bancorp, Inc.
EBSB
| $305K | ﹤0.01% |
+14,912
| New | +$310K |
|
|
ICAD
787
DELISTED
iCAD Inc
ICAD
| $300K | ﹤0.01% |
+17,332
| New | +$304K |
|
788
Voya Financial
VOYA
$8.94B
| $300K | ﹤0.01% |
4,872
-3,393
| -41% | -$223K |
|
789
Henry Schein
HSIC
$9.71B
| $295K | ﹤0.01% |
3,981
-8,041
| -67% | -$606K |
|
790
Fomento Económico Mexicano
FMX
$44.9B
| $294K | ﹤0.01% |
3,484
| – | – |
|
791
Vale
VALE
$62.5B
| $291K | ﹤0.01% |
12,775
-935
| -7% | -$19.5K |
|
792
BCE
BCE
$19.9B
| $279K | ﹤0.01% |
5,644
-77,050
| -93% | -$3.73M |
|
793
American Airlines Group
AAL
$9.68B
| $276K | ﹤0.01% |
13,000
-181,139
| -93% | -$4.1M |
|
|
ZNGA
794
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $273K | ﹤0.01% |
+25,700
| New | +$271K |
|
795
Ingredion
INGR
$6.41B
| $264K | ﹤0.01% |
2,921
-90
| -3% | -$8.4K |
|
796
Pool Corp
POOL
$6.76B
| $255K | ﹤0.01% |
+556
| New | +$234K |
|
797
iShares US Medical Devices ETF
IHI
$3.07B
| $249K | ﹤0.01% |
4,140
| – | – |
|
|
ABMD
798
DELISTED
Abiomed Inc
ABMD
| $238K | ﹤0.01% |
764
-2,470
| -76% | -$758K |
|
799
Vanguard Large-Cap ETF
VV
$51.8B
| $237K | ﹤0.01% |
1,180
| – | – |
|
|
NTCO
800
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $234K | ﹤0.01% |
+10,298
| New | +$202K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.